First Wave BioPharma Inc. Gains 32.7%
Tue, Sep 06, 2022 at 07:27 PM
First Wave BioPharma Inc. (FWBI:NASDAQ) soared at $4.22, representing a gain of 32.7%. On Tue, Sep 06, 2022, FWBI:NASDAQ touched a New 2-Week Intraday High of $4.9. The stock appeared on our News Catalysts scanner on Mon, Aug 29, 2022 at 08:34 AM in the 'MISCELLANEOUS' category. From Tue, Aug 23, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Thu, Mar 31, 2022 at $41.4 with a volume of 1M+.
About First Wave BioPharma Inc. (FWBI:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 91.28%
- IVERIC bio, Inc. (ISEE:NASDAQ), 66.31%
- HyreCar Inc. (HYRE:NASDAQ), 58.12%
- Spero Therapeutics, Inc. (SPRO:NASDAQ), 55.5%
- ChannelAdvisor Corporation (ECOM:NYSE), 55.03%
- Akumin Inc. (AKU:NASDAQ), 36.97%
- Apexigen Inc Com (APGN:NASDAQ), 34.42%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 32.7%
- Galera Therapeutics, Inc. (GRTX:NASDAQ), 29.46%
- HilleVax Inc. (HLVX:NASDAQ), 24.82%